|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003962,
umls-concept:C0007320,
umls-concept:C0011306,
umls-concept:C0022686,
umls-concept:C0030705,
umls-concept:C0079613,
umls-concept:C0085973,
umls-concept:C0198497,
umls-concept:C0205269,
umls-concept:C0220656,
umls-concept:C0854643,
umls-concept:C0855002,
umls-concept:C1879547,
umls-concept:C2003864
|
|
pubmed:dateCreated |
2009-1-5
|
|
pubmed:abstractText |
Malignant ascites is often a sign of a terminal stage in several malignant diseases. To control ascites, drainage and intra-abdominal chemotherapy are often used in those patients but eradication of ascites is difficult and prognosis is poor.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:status |
PubMed-not-MEDLINE
|
|
pubmed:issn |
1752-1947
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
372
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Eradication of intractable malignant ascites by abdominocentesis, reinfusion of concentrated ascites, and adoptive immunotherapy with dendritic cells and activated killer cells in a patient with recurrent lung cancer: a case report.
|
|
pubmed:affiliation |
Department of Thoracic Diseases, Chiba Cancer Center, Chiba, Japan. hkimura@chiba-cc.jp
|
|
pubmed:publicationType |
Journal Article
|
